227 related articles for article (PubMed ID: 24380090)
1. Reassessing the benefits of statins in the prevention of cardiovascular disease in diabetic patients--a systematic review and meta-analysis.
Chang YH; Hsieh MC; Wang CY; Lin KC; Lee YJ
Rev Diabet Stud; 2013; 10(2-3):157-70. PubMed ID: 24380090
[TBL] [Abstract][Full Text] [Related]
2. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
3. Statins for the primary prevention of cardiovascular disease.
Taylor F; Huffman MD; Macedo AF; Moore TH; Burke M; Davey Smith G; Ward K; Ebrahim S
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004816. PubMed ID: 23440795
[TBL] [Abstract][Full Text] [Related]
4. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
6. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
Schmidt AF; Carter JL; Pearce LS; Wilkins JT; Overington JP; Hingorani AD; Casas JP
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011748. PubMed ID: 33078867
[TBL] [Abstract][Full Text] [Related]
7. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
8. Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?
Agouridis AP; Rizos CV; Elisaf MS; Filippatos TD
Rev Diabet Stud; 2013; 10(2-3):171-90. PubMed ID: 24380091
[TBL] [Abstract][Full Text] [Related]
9. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.
de Vries FM; Denig P; Pouwels KB; Postma MJ; Hak E
Drugs; 2012 Dec; 72(18):2365-73. PubMed ID: 23186103
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
11. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials.
Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130
[TBL] [Abstract][Full Text] [Related]
12. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
Schmidt AF; Pearce LS; Wilkins JT; Overington JP; Hingorani AD; Casas JP
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011748. PubMed ID: 28453187
[TBL] [Abstract][Full Text] [Related]
13. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
[TBL] [Abstract][Full Text] [Related]
14. Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis.
Nayak A; Hayen A; Zhu L; McGeechan K; Glasziou P; Irwig L; Doust J; Gregory G; Bell K
BMJ Open; 2018 Oct; 8(9):e020584. PubMed ID: 30287603
[TBL] [Abstract][Full Text] [Related]
15. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
Sanders RD; Nicholson A; Lewis SR; Smith AF; Alderson P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009971. PubMed ID: 23824754
[TBL] [Abstract][Full Text] [Related]
16. Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials.
Lee M; Cheng CY; Wu YL; Lee JD; Hsu CY; Ovbiagele B
JAMA Neurol; 2022 Apr; 79(4):349-358. PubMed ID: 35188949
[TBL] [Abstract][Full Text] [Related]
17. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
[TBL] [Abstract][Full Text] [Related]
18. HMG CoA reductase inhibitors (statins) for dialysis patients.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
[TBL] [Abstract][Full Text] [Related]
19. Statin use and the risk of CVD events, stroke, and all-cause mortality in patients with diabetes: A systematic review and meta-analysis.
Yang XH; Zhang BL; Cheng Y; Fu SK; Jin HM
Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2470-2482. PubMed ID: 36064686
[TBL] [Abstract][Full Text] [Related]
20. Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study.
Sasso FC; Lascar N; Ascione A; Carbonara O; De Nicola L; Minutolo R; Salvatore T; Rizzo MR; Cirillo P; Paolisso G; Marfella R;
Cardiovasc Diabetol; 2016 Oct; 15(1):147. PubMed ID: 27733159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
